|+33 1 72 69 01 86|
|Corinne Duguet, MD|
|+ 33 1 72 69 01 86|
Male or female patients with symptomatic SCD,
≥ 2 years old,
Treated with Siklos®,
Having been informed of the study by the investigator and consenting to participate, or whose parents or legal guardians are consenting for their child to participate.
To allow risk evaluation, participants must belong at least to one of the subpopulations defined below:
Participants previously enrolled in ESCORT-HU who agree to participate in ESCORT-HU Extension study,
New participants with any of the following criteria:
history of HU treatment for more than 5 years or
prepubescent over 10 years of age for girls and 13 years of age for boys at enrolment, or
with history of leg ulcer, or
pregnant women without interruption of Siklos® 3 months before the beginning of the pregnancy or,
males treated with Siklos® whose partner is pregnant and without discontinuation of Siklos® 3 months before the beginning of the pregnancy.